Lotus Bio-Technology Development Corp
OTC:LBTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lotus Bio-Technology Development Corp
OTC:LBTD
|
US |
|
A
|
ARB Corp Ltd
OTC:ARBFF
|
AU |
|
Republic Airways Holdings Inc
F:M2A0
|
US |
|
G
|
Gap Inc
DUS:GAP
|
US |
|
M
|
Marie Brizard Wine and Spirits SA
F:BED
|
FR |
|
E
|
Edison International
XMUN:EIX
|
US |
|
L
|
Lloyds Banking Group PLC
XHAM:LLD
|
UK |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
F
|
First Pacific Co Ltd
XMUN:FPC
|
HK |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Lotus Bio-Technology Development Corp.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Lotus Bio-Technology Development Does
Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections.
- Headquarters
- United States of America US
- IPO date
- Mar 14, 2013